Catalysts for Somerset Therapeutics LLC
28 tracked
Apr 1, 2026
approval
PROCHLORPERAZINE EDISYLATE โ FDA approval
PROCHLORPERAZINE EDISYLATE
โ
Mar 25, 2026
recall
SOMERSET THERAPEUTICS LLC recall (Cls II)
Somerset Therapeutics LLC
โ
Jan 29, 2026
approval
RILPIVIRINE HYDROCHLORIDE โ FDA approval
rilpivirine hydrochloride ODT
โ
Jan 20, 2026
approval
SACUBITRIL AND VALSARTAN (SACUBITRIL) โ FDA approval
SACUBITRIL AND VALSARTAN
โ
Jan 14, 2026
approval
ELTROMBOPAG OLAMINE โ FDA approval
ELTROMBOPAG OLAMINE
โ
Dec 24, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
โ
Dec 24, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
โ
Dec 24, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
โ
Dec 22, 2025
approval
NALBUPHINE HYDROCHLORIDE โ FDA approval
NALBUPHINE HYDROCHLORIDE
โ
Dec 22, 2025
approval
NALBUPHINE HYDROCHLORIDE โ FDA approval
NALBUPHINE HYDROCHLORIDE
โ
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Sep 26, 2025
approval
ACETYLCYSTEINE โ FDA approval
ACETYLCYSTEINE
โ
Sep 23, 2025
approval
LEUPROLIDE ACETATE โ FDA approval
LEUPROLIDE ACETATE
โ
Apr 30, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 30, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 30, 2025
recall
Amerisource Health Services LLC recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
โ
Apr 16, 2025
recall
Somerset Therapeutics Private Limited recall (Cls II)
Somerset Therapeutics LLC
โ
Feb 12, 2025
approval
ACETYLCYSTEINE โ FDA approval
ACETYLCYSTEINE
โ
Jan 30, 2025
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jan 8, 2025
recall
SOMERSET THERAPEUTICS LLC recall (Cls III)
Somerset Therapeutics LLC
โ
Sep 19, 2024
approval
NALBUPHINE HYDROCHLORIDE โ FDA approval
NALBUPHINE HYDROCHLORIDE
โ
Sep 19, 2024
approval
NALBUPHINE HYDROCHLORIDE โ FDA approval
NALBUPHINE HYDROCHLORIDE
โ
Sep 13, 2024
approval
PROCHLORPERAZINE EDISYLATE โ FDA approval
PROCHLORPERAZINE EDISYLATE
โ
Aug 13, 2021
approval
LEUPROLIDE ACETATE โ FDA approval
LEUPROLIDE ACETATE
โ